Extracellular vesicles derived-microRNAs predicting enzalutamide-resistance in 3D spheroid prostate Cancer model

被引:0
|
作者
Tavares, Ines [1 ,2 ]
Morais, Mariana [1 ,2 ]
Dias, Francisca [1 ]
Ferreira, Mariana [1 ,2 ]
Martins, Gabriela [3 ]
Fernandes, Rui [4 ,5 ]
Bidarra, Silvia Joana [6 ,7 ]
Medeiros, Rui [1 ,2 ,8 ,9 ,10 ]
Teixeira, Ana Luisa [1 ]
机构
[1] Portuguese Oncol Inst Porto IPO Porto, Res Ctr IPO Porto CI IPOP, RISECI IPOP Hlth Res Network, Porto Comprehens Canc Ctr Raquel Seruca Porto CCC,, Porto, Portugal
[2] Univ Porto, Abel Salazar Inst Biomed Sci, ICBAS, Porto, Portugal
[3] Portuguese Oncol Inst Porto IPO Porto, Dept Immunol, Porto, Portugal
[4] Univ Porto, HEMS Histol & Electron Microscopy, Inst Invest & Inovacao Saude I3S, Porto, Portugal
[5] Univ Porto, IBMC Inst Biol Mol & Celular, Porto, Portugal
[6] Univ Porto, Inst Invest & Inovacao Saude I3S, Bioengn 3D Microenvironm Grp, Porto, Portugal
[7] Univ Porto, INEB Inst Engn Biomed, Porto, Portugal
[8] Fernando Pessoa Univ UFP, Fac Hlth Sci, Biomed Reasearch Ctr CEBIMED, Porto, Portugal
[9] Portuguese League Canc LPCC NRNorte, Res Dept, Porto, Portugal
[10] Univ Porto, Fac Med Univ Porto FMUP, Porto, Portugal
关键词
Prostate cancer; Resistance acquisition; Extracellular vesicles derived-miRNAs; Predictive biomarkers; 2ND-GENERATION ANTIANDROGEN; EXPRESSION; DISEASES; MIR-221; GROWTH;
D O I
10.1016/j.ijbiomac.2024.137993
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Enzalutamide (ENZ) has emerged as a major treatment advance in castration-resistant prostate cancer (CRPC) patients; however the development of resistance remains a key challenge. The extracellular vesicles (VEs)derived miRNAs play crucial roles tumor microenvironment cell communication, thereby influencing resistance mechanisms. Considering the urgent need for molecular biomarkers to monitor ENZ response and predict resistance, we intend to identify an EV-derived miRNA profile associated with ENZ resistance using an innovative 3D-spheroid in vitro model. Through the generation of this model, we provide a comprehensive platform for elucidating the molecular alterations involved in the process. An in vitro model of ENZ resistance was established through continuous exposure of LNCaP to increasing ENZ concentrations. A screening of 799 miRNAs from resistant and normal LNCaP cells were quantified. A bioinformatic analysis was performed using miRTarbase and Cytoscape and top 5 overexpressed miRNAs were selected, that will be analyzed in extracellular vesicles derived from ENZ resistance 3D spheroid models. We identified 12 up- and 13 downregulated miRNAs in LNCaP 30 mu M ENZ cells compare to LNCaP & sdot;In silico analysis led to the construction of a 76 proteins cluster and functional enrichment revealed terms like PI3K/AKT, TFG-beta and FOXO. hsa-miR-22-3p was significantly decreased at 5 and 20 mu M ENZ concentration intracellularly, but significantly increased at 20 mu M ENZ in EVs. hsa-miR-221-3p and miR-222-3p were upregulated in all concentrations both intracellularly and in EVs. The developed 3D-spheroid model effectively replicated the ENZ resistance to ENZ in an AR-independent manner, underscoring the importance of EVs-derived miRNAs in this adaptive process.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Time-Resolved Fluorescence Imaging and Analysis of Cancer Cell Invasion in the 3D Spheroid Model
    Perrin, Louisiane
    Tucker, Theodore
    Gligorijevic, Bojana
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (167):
  • [42] Nano-vesicular formulation of propolis and cytotoxic effects in a 3D spheroid model of lung cancer
    Ilhan-Ayisigi, Esra
    Ulucan, Fulden
    Saygili, Ecem
    Saglam-Metiner, Pelin
    Gulce-Iz, Sultan
    Yesil-Celiktas, Ozlem
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2020, 100 (08) : 3525 - 3535
  • [43] The Microwell-mesh: A high-throughput 3D prostate cancer spheroid and drug-testing platform
    Mosaad, E. O.
    Chambers, K. F.
    Futrega, K.
    Clements, J. A.
    Doran, M. R.
    SCIENTIFIC REPORTS, 2018, 8
  • [44] The Microwell-mesh: A high-throughput 3D prostate cancer spheroid and drug-testing platform
    E. O. Mosaad
    K. F. Chambers
    K. Futrega
    J. A. Clements
    M. R. Doran
    Scientific Reports, 8
  • [45] Overcoming TRAIL-resistance by sensitizing prostate cancer 3D spheroids with taxanes
    Grayson, Korie A.
    Jyotsana, Nidhi
    Ortiz-Otero, Nerymar
    King, Michael R.
    PLOS ONE, 2021, 16 (03):
  • [46] Cancer Stem Cell Derived Extracellular Vesicles with Self-Functionalized 3D Nanosensor for Real-Time Cancer Diagnosis: Eliminating the Roadblocks in Liquid Biopsy
    Haldavnekar, Rupa
    Venkatakrishnan, Krishnan
    Tan, Bo
    ACS NANO, 2022, 16 (08) : 12226 - 12243
  • [47] Genomic 3D structural changes in prostate cancer are associated with the acquisition of castration resistance
    Kanaoka, Sanji
    Okabe, Atsushi
    Kanesaka, Manato
    Hoshii, Takayuki
    Fukuyo, Masaki
    Nawai, Bahityar R.
    Sakamoto, Shinichi
    Komiya, Akira
    Ichikawa, Tomohiko
    Kaneda, Atsushi
    CANCER SCIENCE, 2022, 113 : 1730 - 1730
  • [48] Developing a patient derived 3D co-culture model of prostate organoids to examine biological mechanisms involved in prostate cancer disparities
    Marsili, Joseph
    Richards, Zachary
    Garcia, Jason
    Voisine, Cindy
    Nonn, Larisa
    CANCER RESEARCH, 2017, 77
  • [49] IN VITRO DEVELOPMENT OF 3D CELL-DERIVED EXTRACELLULAR MATRICES FOR COLORECTAL CANCER MODELING
    Rubi-Sans, Gerard
    Nyga, Agata
    Camps, Jordi
    Perez-Amodio, Soledad
    Mateos-Timoneda, Miguel A.
    Engel, Elisabeth
    Blanco-Fernandez, Barbara
    TISSUE ENGINEERING PART A, 2022, 28 : S217 - S217
  • [50] Investigating Extracellular Vesicle crosstalk using a 3D dynamic model of Breast Cancer
    Chabria, Yashna
    Lowery, Aoife J.
    Duffy, Garry P.
    Dwyer, Roisin M.
    TISSUE ENGINEERING PART A, 2023, 29 (13-14)